Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03561896 : Hypofractionated Brain Radiationcavity
AgesMin: 18 Years Max: N/A
Inclusion criteria:

- Patient underwent surgery for single brain metastasis arising from solid neoplasia
(lung, breast, melanoma, kidney, colorectal), with initial histological diagnosis.

- Selected cases with a resected lesion and a further non-resected lesion (from 1 to 2
lesions), treatable with SRS / IGRT of the surgical cavity

- Patient = 18 years

- Willngness to participate in the study, written informed consent

- Performance Status according to WHO 0-I

- Good general conditions and organ function

- Newly diagnosed chemotherapy-naïve disease or controlled systemic disease

- Good bone marrow, renal and hepatic function

- Stable steroid dose or reduced for at least 5 days

Exclusion Criteria:

- History of previous brain irradiation

- Pregnancy or breastfeeding

- Histological diagnosis other than lung, breast, melanoma, kidney and colorectal
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557